Pharmacology News and Research

Latest Pharmacology News and Research

Consumption of highly refined fiber may increase liver cancer risk in some people

Many people commonly consume fiber-enriched foods to promote weight loss and prevent chronic diseases such as diabetes and cancer.

26 Sep 2022

New discovery changes the understanding of Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is caused by a genetic mutation and affects one in every 5,000 boys born. Because the affected gene is on the X chromosome, girls are carriers of the mutant gene but develop the disease only very rarely (one in about 50 million).

26 Sep 2022

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

In a new paper, University of California, Irvine researchers explain how precision genome editing agents have enabled precise gene correction and disease rescue in inherited retinal diseases (IRDs).

23 Sep 2022

Recommendations for the treatment, prevention of monkeypox in nursing mothers

Although none of the preventative or therapeutic agents used in monkeypox have been fully studied in nursing mothers, Philip Anderson, PharmD, from the University of California, San Diego, presents a broad practical recommendation for the treatment and prevention of monkeypox in nursing mothers in an article published in the peer-reviewed journal Breastfeeding Medicine.

20 Sep 2022

Large molecules glom together into dense droplets to create squishy circuits in cells

An emerging field explores how groups of molecules condense together inside cells, the way oil droplets assemble and separate from water in a vinaigrette.

14 Sep 2022

C-Path secures FDA Grant for new public-private partnership to benefit people with rare neurodegenerative diseases

Critical Path Institute has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases, a new public-private partnership to benefit people across multiple rare neurodegenerative diseases, supported by a grant from the U.S. Food and Drug Administration.

14 Sep 2022

$Worldwide hip fracture counts likely to double by 2050, study finds$

Worldwide hip fracture counts likely to double by 2050, study finds

Osteoporotic hip fracture, already a dangerous and debilitating problem for older men and women worldwide, is poised to become a far more severe global public-health issue as the population grows older and frailer, according to a new study led by researchers at the University of Hong Kong.

12 Sep 2022

Phase III ADAURA trial reveals promising results for patients with non-small cell lung cancer

Newly released results from the Phase III ADAURA trial reveal that osimertinib yielded a 5.5-year median disease-free survival in the post-surgical treatment of patients with EGFR-mutated lung cancer, and nearly three in four patients treated with adjuvant osimertinib were disease-free at four years.

12 Sep 2022

Study shortlists potential drug repurposing candidates to treat symptoms in ASD

Can you teach an old drug new tricks? Although drug treatments for the core symptoms of autism spectrum disorder (ASD) are not currently available, could an existing drug provide a new treatment, even if it previously had no association with ASD? This was the question asked by a new study in the journal Frontiers in Pharmacology. The researchers used a computer model that encompasses proteins involved in ASD and the way they interact.

12 Sep 2022

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

A novel treatment strategy with personalized cell therapy significantly improves progression-free survival compared to standard immunotherapy in patients with advanced melanoma, according to ground-breaking results reported at the ESMO Congress 2022 from the phase 3 M14TIL trial.

12 Sep 2022

HKUMed team estimates a moderate link between antipsychotic use and breast cancer by over 30%

A research team from the Centre for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) conducted the world's first systematic review and meta-analysis of observational studies with over two million individuals and estimated a moderate association between antipsychotic use and breast cancer by over 30%.

9 Sep 2022

Licorice compounds proposed as effective candidates for treatment of COVID-19

Researchers describe the different mechanisms by which licorice active ingredients target SARS-CoV-2.

8 Sep 2022

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.

8 Sep 2022

Study establishes link between Piezo1 and intracellular cholesterol levels during neural development

A new University of California, Irvine-led study reveals how mechanical forces and tissue mechanics influence the morphology of the developing brain, and establishes a direct link in neural stem cells between Piezo1, a mechanically-activated ion channel, and intracellular cholesterol levels during neural development.

8 Sep 2022

Pharmacology News and Research

Latest Pharmacology News and Research

Consumption of highly refined fiber may increase liver cancer risk in some people

New discovery changes the understanding of Duchenne muscular dystrophy

Genome editing approaches enable precise gene correction and disease rescue in inherited retinal diseases

Recommendations for the treatment, prevention of monkeypox in nursing mothers

Large molecules glom together into dense droplets to create squishy circuits in cells

C-Path secures FDA Grant for new public-private partnership to benefit people with rare neurodegenerative diseases

Worldwide hip fracture counts likely to double by 2050, study finds

Phase III ADAURA trial reveals promising results for patients with non-small cell lung cancer

Study shortlists potential drug repurposing candidates to treat symptoms in ASD

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

HKUMed team estimates a moderate link between antipsychotic use and breast cancer by over 30%

Licorice compounds proposed as effective candidates for treatment of COVID-19

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

Study establishes link between Piezo1 and intracellular cholesterol levels during neural development

Total lockdown during COVID-19 has measurable impact on vascular health, research shows

Lactate may have a previously unrecognized role in fighting cancer

Trial compares two different lung volume reduction procedures for people with emphysema

Researchers secure $20.5 million NIH grant to beat Alzheimer's disease and related dementias

Leukemia drug successfully disrupts HER2-positive brain metastasis in animal studies

Vitamin D mediates crosstalk between COVID-19 and osteoporosis

Pittcon Highlights: Pharmaceutical & Biologic eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in